연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2020년 | 2019년 | 2018년 | 2017년 | 2016년 | 합계 |
|---|---|---|---|---|---|---|
| 발표논문 | 303편 | 311편 | 124편 | 125편 | 161편 | 1024편 |
2791. Treatment strategy for papillary renal cell carcinoma type 2: a case series of seven patients treated based on next generation sequencing data
Ji-Yeon Kim 1 2 , Hyoung-Oh Jeong 3 4 , Dae Seog Heo 2 5 , Bhumsuk Keam 2 5 , Kyung Chul Moon 6 , Cheol Kwak 7 , Jinho Jang 3 4 , Seunghoon Kim 3 4 , Jong-Il Kim 8 9 , Semin Lee 3 4 , Se-Hoon Lee 1 2 10
Ann Transl Med . 2020 Nov;8(21):1389.
Link
2790. Immunophenotypic Landscape and Prognosis of Diffuse Large B-Cell Lymphoma with MYC/BCL2 Double Expression: An Analysis of A Prospectively Immunoprofiled Cohort
Bogyeong Han 1 , Sehui Kim 1 2 , Jiwon Koh 1 , Jeemin Yim 1 , Cheol Lee 1 , Dae Seog Heo 2 3 , Tae Min Kim 2 3 , Jin Ho Paik 4 , Yoon Kyung Jeon 1 2
Cancers (Basel)
. 2020 Nov 9;12(11):3305.
Link
2789. Oncologic outcomes after immediate breast reconstruction following mastectomy: comparison of implant and flap using propensity score matching
Ha JH, Hong KY, Lee HB, Moon HG, Han W, Noh DY, Lim J, Yoon S, Chang H, Jin US.
BMC Cancer. 2020 Jan 30;20(1):78.
Link
2788. OPENchip: an on-chip in situ molecular profiling platform for gene expression analysis and oncogenic mutation detection in single circulating tumour cells
Lee AC, Svedlund J, Darai E, Lee Y, Lee D, Lee HB, Kim SM, Kim O, Bae HJ, Choi A, Lee S, Jeong Y, Song SW, Choi Y, Yeom H, Lee CS, Han W, Lee DS, Jang JY, Madaboosi N, Nilsson M, Kwon S.
Lab Chip. 2020 Mar 3;20(5):912-922.
Link
2787. A Review of the Epidemiology of Breast Cancer in Asia: Focus on Risk Factors
Youn HJ, Han W.
Asian Pac J Cancer Prev. 2020 Apr 1;21(4):867-880.
Link
2786. Protein Kinase A Catalytic Subunit Is a Molecular Switch that Promotes the Pro-tumoral Function of Macrophages
Na YR, Kwon JW, Kim DY, Chung H, Song J, Jung D, Quan H, Kim D, Kim JS, Ju YW, Han W, Ryu HS, Lee YS, Hong JJ, Seok SH.
Cell Rep. 2020 May 12;31(6):107643.
Link
2785. Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer
Kim HJ, Noh WC, Lee ES, Jung YS, Kim LS, Han W, Nam SJ, Gong G-, Kim HJ, Ahn SH.
Breast Cancer Res. 2020 May 27;22(1):54.
Link
2784. Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer
Lim S, Kim Y, Lee SB, Kang HG, Kim DH, Park JW, Chung D, Kong H, Yoo KH, Kim Y, Han W, Chun KH, Park JH.
Oncogenesis. 2020 Oct 11;9(10):91.
Link
2783. Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by an intelligent vacuum-assisted biopsy
Pfob A, Sidey-Gibbons C, Lee HB, Tasoulis MK, Koelbel V, Golatta M, Rauch GM, Smith BD, Valero V, Han W, MacNeill F, Weber WP, Rauch G, Kuerer HM, Heil J.
Eur J Cancer. 2020 Dec 8;143:134-146.
Link
2782. Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis
Kim DY, Park E, Heo CY, Jin US, Kim EK, Han W, Shin KH, Kim IA.
Breast. 2020 Dec 1;55:37-44.
Link